Edition:
United Kingdom

argenx SE (ARGX.BR)

ARGX.BR on Brussels Stock Exchange

107.60EUR
4:39pm BST
Change (% chg)

€4.40 (+4.26%)
Prev Close
€103.20
Open
€104.10
Day's High
€108.00
Day's Low
€104.10
Volume
88,859
Avg. Vol
118,788
52-wk High
€119.60
52-wk Low
€54.30

About

argenx SE, formerly arGEN X BV, is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused... (more)

Overall

Beta: --
Market Cap(Mil.): €583.54
Shares Outstanding(Mil.): 26.89
Dividend: --
Yield (%): --

Financials

  ARGX.BR Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -1.07 -- --
ROI: -19.69 8.91 13.83
ROE: -19.69 10.06 15.25

Earnings vs. Estimates